Classification of missense substitutions in the BRCA genes: A database dedicated to Ex-UVs
Open Access
- 11 October 2011
- journal article
- databases
- Published by Hindawi Limited in Human Mutation
- Vol. 33 (1), 22-28
- https://doi.org/10.1002/humu.21629
Abstract
Unclassified sequence variants (UVs) arising from clinical mutation screening of cancer susceptibility genes present a frustrating issue to clinical genetics services and the patients that they serve. We created an open‐access database holding missense substitutions from the breast and ovarian cancer susceptibility genes BRCA1 and BRCA2. The main inclusion criterion is that each variant should have been assessed in a published work that used the Bayesian integrated evaluation of unclassified BRCA gene variants. Transfer of data on these substitutions from the original publications to our database afforded an opportunity to analyze the missense substitutions under a single model and to remove inconsistencies that arose during the evolution of the integrated evaluation over the last decade. This analysis also afforded the opportunity to reclassify these missense substitutions according to the recently published IARC 5‐Class system. From an initial set of 248 missense substitutions, 31 were set aside due to nonnegligible probability to interfere with splicing. Of the remaining substitutions, 28 fell into one of the two pathogenic classes (IARC Class 4 or 5), 174 fell into one of the two nonpathogenic classes (IARC Class 1 or 2), and 15 remain in IARC Class 3, “Uncertain.” The database is available at http://brca.iarc.fr/LOVD. Hum Mutat 33:22–28, 2012.Keywords
This publication has 31 references indexed in Scilit:
- DBASS3 and DBASS5: databases of aberrant 3'- and 5'-splice sitesNucleic Acids Research, 2010
- Assessment of functional effects of unclassified genetic variantsHuman Mutation, 2008
- Genetic evidence and integration of various data sources for classifying uncertain variants into a single modelHuman Mutation, 2008
- Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significanceHuman Mutation, 2008
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test resultsHuman Mutation, 2008
- Functional Assays for Classification ofBRCA2Variants of Uncertain SignificanceCancer Research, 2008
- Evaluation of in silico splice tools for decision-making in molecular diagnosisHuman Mutation, 2008
- A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer–Predisposition GenesAmerican Journal of Human Genetics, 2007
- Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing SignalsJournal of Computational Biology, 2004
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995